Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02844090

Ligand	Ligand name	Chain	PDB	Tanimoto
OTS	4-(2S-AMINO-1-HYDROXYETHYL)PHENOL	A,B	1RG2	0.75
OTS	4-(2S-AMINO-1-HYDROXYETHYL)PHENOL	A,B	1RG1	0.75
OTS	4-(2S-AMINO-1-HYDROXYETHYL)PHENOL	A,B	1RH0	0.75
OTS	4-(2S-AMINO-1-HYDROXYETHYL)PHENOL	A,B	1RGU	0.75
OTS	4-(2S-AMINO-1-HYDROXYETHYL)PHENOL	A,B	1RGT	0.75
790	1,2,3,4-TETRAHYDROQUINOLIN-8-YL DIHYDROGEN PHOSPHATE	A	1O4F	0.7
SAF	3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL	A	1GQR	0.82
SAF	3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL	A	1GQS	0.82
LDP	L-DOPAMINE	A,B	2A3R	0.72
LDP	L-DOPAMINE	A	5PAH	0.72
LDP	L-DOPAMINE	A,B	2QMZ	0.72
LDP	L-DOPAMINE	A,B	2VQ5	0.72
OTR	4-(2R-AMINO-1-HYDROXYETHYL)PHENOL	A,B	1RGT	0.75
OTR	4-(2R-AMINO-1-HYDROXYETHYL)PHENOL	A,B	1RG2	0.75
OTR	4-(2R-AMINO-1-HYDROXYETHYL)PHENOL	A,B	2AN4	0.75
REN	(S)-reticuline	A	3FWA	0.78
REN	(S)-reticuline	A	3D2D	0.78
AOE	N-BUTYL-11-[(7R,8R,9S,13S,14S,17S)-3,17-DIHYDROXY-13-METHYL-7,8,9,11,12,13,14,15,16,17-DECAHYDRO-6H-CYCLOPENTA[A]PHENANTHREN-7-YL]-N-METHYLUNDECANAMIDE	A	1HJ1	0.71
TTL	TRANS-(1S,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL	A,B	2AN5	0.7
AEG	4-[(2R)-2-aminopropyl]phenol	A	3BUF	0.71
SLX	(13aS)-3,10-dimethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline-2,9-diol	A	3FW9	0.76
CM3	(2R,3R,4S)-5-FLUORO-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PIPERIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL	A	1YIN	0.71
MA0	(1R)-6-HYDROXY-N-METHYL-N-[(1Z)-PROP-2-EN-1-YLIDENE]INDAN-1-AMINIUM	A,B	2C64	0.77
AEF	4-(2-aminoethyl)phenol	A	3BRA	0.71
GNT	(-)-GALANTHAMINE	A	1DX6	0.73
GNT	(-)-GALANTHAMINE	A	1QTI	0.73
GNT	(-)-GALANTHAMINE	A,B,C,D,E	2PH9	0.73
GNT	(-)-GALANTHAMINE	A,B	1W76	0.73
GNT	(-)-GALANTHAMINE	A	1W6R	0.73
CTL	CIS-(1R,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL	A,B	2AN3	0.7
VBZ	(1R,4R,5R,7R,8R)-2-Benzyl-5-hydroxymethyl-2-aza-bicyclo[2.2.2]octane-4,7,8-triol	A,B	2VO5	0.71
3QC	(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE	A,B	2FME	0.8
RHP	(3R)-3-(PROP-2-YNYLAMINO)INDAN-5-OL	A,B	1S3E	0.76
PTI	2-PHENYL-1-[4-(2-PIPERIDIN-1-YL-ETHOXY)-PHENYL]-1,2,3,4-TETRAHYDRO-ISOQUINOLIN-6-OL	A	1UOM	0.71
AHT	4-(2,5-DIAMINO-5-HYDROXY-PENTYL)-PHENOL	I,T	1TMB	0.72
LNR	L-NOREPINEPHRINE	A,B	2QEO	0.75
LNR	L-NOREPINEPHRINE	A	3DYE	0.75
LNR	L-NOREPINEPHRINE	A	4PAH	0.75
RM2	4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN	A,B	2C66	0.72
2MP	3,4-DIMETHYLPHENOL	A	1L5O	0.71
BM4	3-[(3R)-3-ethyl-1-{9-[(3S)-3-ethyl-3-(3-hydroxyphenyl)azepan-1-yl]nonyl}azepan-3-yl]phenol	X	2W6C	0.74
ALE	L-EPINEPHRINE	A	3PAH	0.79
ALE	L-EPINEPHRINE	A	2HKK	0.79
CMZ	(2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol	A	2OF0	0.71
G27	(3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL	A	2G9R	0.7
G27	(3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL	A	2G9U	0.7
099	(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide	A,B	3HYG	0.71
CM4	(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL	A	1YIM	0.71
AEJ	(1S)-1-{4-[(9AR)-OCTAHYDRO-2H-PYRIDO[1,2-A]PYRAZIN-2-YL]PHENYL}-2-PHENYL-1,2,3,4-TETRAHYDROISOQUINOLIN-6-OL	A,B,C,D	1XQC	0.71
AEH	4-(2-aminoethyl)-2-ethylphenol	A	3BUG	0.71